Image for Voyager Clinical Trial

VOYAGER

A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).

Location Description

The First Affiliated Hospital of Xinjiang Medical University is committed to providing exceptional service through their multidisciplinary care and clinical research.

Ürümqi, China Clinical Trial Location

First Affiliated Hospital of Xinjiang Medical University
Xinshi District,
Ürümqi, Ürümqi, China